{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:11:20Z","timestamp":1764835880806,"version":"3.46.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction and importance:<\/jats:title>\n                    <jats:p>Neurologic disorders are among the most significant clinical symptoms of systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), primarily affecting the central nervous system. Both SLE and APS increase the risk of cerebrovascular events, and stroke is one of the most serious and late consequences that often occur years after diagnosis. Stroke as an initial symptom is uncommon in its early stages and frequently misinterpreted as ischemic cerebrovascular illness, posing diagnostic challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report:<\/jats:title>\n                    <jats:p>A 15-year-old female patient presented to the emergency department with a history of right-sided body weakness, mouth deviation, and dysarthria. A brain MRI revealed a complete occlusion of the left MCA with multiple acute left periventricular ischemia. She was referred for urgent brain catheterization, where complete recanalization of the MCA was performed. Extensive investigations were performed, including serological laboratory studies, which led to a subsequent diagnosis of SLE and APS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical discussion:<\/jats:title>\n                    <jats:p>Ischemic stroke is a serious and late consequence of SLE and APS that often occurs years after diagnosis. Ischemic stroke as an initial symptom is uncommon in its early stages and frequently misinterpreted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This case exemplifies a sudden and possibly fatal presentation of SLE and APS in pediatric patients, emphasizing the need of early recognition and tailored treatment in influencing the disease\u2019s progression and outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000003317","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T03:00:18Z","timestamp":1745204418000},"page":"3935-3939","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Acute stroke as the initial manifestation of neuropsychiatric lupus erythematosus and anti-phospholipid syndrome in a child patient"],"prefix":"10.1097","volume":"87","author":[{"given":"Saif","family":"Sadeh","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Al-Quds University, Jerusalem, Palestine"},{"name":"Hebron Governmental Hospital, Hebron, Palestine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0898-146X","authenticated-orcid":false,"given":"Mariam","family":"Thalji","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Al-Quds University, Jerusalem, Palestine"},{"name":"Faculty of Medicine, Palestine Polytechnic University, Hebron, Palestine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakam","family":"Shrouf","sequence":"additional","affiliation":[{"name":"Hebron Governmental Hospital, Hebron, Palestine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharif","family":"Basal","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Al-Ahli Hospital, West Bank, Palestine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saed I Y","family":"Attawna","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Al-Ahli Hospital, West Bank, Palestine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"R1-20251204","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: a review [published correction appears in JAMA","volume":"331","author":"Siegel","year":"2024","journal-title":"JAMA"},{"key":"R2-20251204","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/0961203316688784","article-title":"Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment","volume":"26","author":"de Amorim","year":"2017","journal-title":"Lupus"},{"key":"R3-20251204","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2005-01-0330","article-title":"Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation","volume":"106","author":"Statkute","year":"2005","journal-title":"Blood"},{"key":"R4-20251204","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/25785826.2020.1770947","article-title":"Diversity of neuropsychiatric manifestations in systemic lupus erythematosus","volume":"43","author":"Fujieda","year":"2020","journal-title":"Immunol Med"},{"key":"R5-20251204","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"R6-20251204","first-page":"47","article-title":"The incidence and prognosis of central nervous system disease in systemic lupus erythematosus","volume":"19","author":"Sibley","year":"1992","journal-title":"J Rheumatol"},{"key":"R7-20251204","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12959-015-0043-3","article-title":"Systemic lupus erythematosus and thrombosis","volume":"13","author":"Bazzan","year":"2015","journal-title":"Thromb J"},{"key":"R8-20251204","doi-asserted-by":"crossref","first-page":"e1183","DOI":"10.1002\/iid3.1183","article-title":"Three cases of systemic lupus erythematosus presenting with ischemic stroke as the initial symptom: case reports and literature review","volume":"12","author":"Li","year":"2024","journal-title":"Immun Inflamm Dis"},{"key":"R9-20251204","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13317-019-0119-3","article-title":"Antiphospholipid syndrome: a case report with an unusual wide spectrum of clinical manifestations","volume":"10","author":"Mazzoccoli","year":"2019","journal-title":"Auto Immun Highlights"},{"key":"R10-20251204","first-page":"190","article-title":"Manifestaciones relacionadas con alteraciones en la coagulaci\u00f3n en lupus eritematoso sist\u00e9mico de inicio juvenil. Reporte de casos y revisi\u00f3n de la literatura","volume":"27","author":"Mf Sml","year":"2020","journal-title":"Rev Colomb Reumatol"},{"key":"R11-20251204","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2007.070367","article-title":"EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics","volume":"67","author":"Bertsias","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R12-20251204","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","author":"Liang","year":"1999","journal-title":"Am Coll Rheumatol Arthritis & Rheumatism"},{"key":"R13-20251204","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R14-20251204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/svn-2022-001499","article-title":"Ten-year follow-up investigation of stroke risk in systemic lupus erythematosus","volume":"9","author":"Huang","year":"2024","journal-title":"Stroke Vasc Neurol"},{"key":"R15-20251204","doi-asserted-by":"crossref","first-page":"e000168","DOI":"10.1136\/rmdopen-2015-000168","article-title":"Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies","volume":"1","author":"Holmqvist","year":"2015","journal-title":"RMD Open"},{"key":"R16-20251204","first-page":"894","article-title":"The necessity of stroke prevention in patients with systemic lupus erythematosus","volume":"17","author":"Saadatnia","year":"2012","journal-title":"J Res Med Sci: The Offic J Isfahan Uni Med Sci"},{"key":"R18-20251204","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/biom13040617","article-title":"An antiphospholipid antibody profile as a biomarker for thrombophilia in systemic lupus erythematosus","volume":"13","author":"Hisada","year":"2023","journal-title":"Biomolecules"},{"key":"R19-20251204","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/art.23109","article-title":"A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies","volume":"57","author":"Ruiz-Irastorza","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R20-20251204","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11926-010-0141-y","article-title":"Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients","volume":"13","author":"Petri","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"R21-20251204","first-page":"18","article-title":"Influence of statin therapy on antiphospholipid antibodies and endothelial dysfunction in young patients with coronary artery disease and systemic lupus erythematosus","volume":"18","author":"Mazurek","year":"2020","journal-title":"Arch Med Sci: AMS"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:06:20Z","timestamp":1764835580000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003317","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"electronic","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"2025-01-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}